Modelling SARS-CoV-2 Binding Antibody Waning 8 Months after BNT162b2 Vaccination

Several lines of evidence suggest that binding SARS-CoV-2 antibodies such as anti-SARS-CoV-2 RBD IgG (anti-RBD) and neutralising antibodies (NA) are correlates of protection against SARS-CoV-2, and the correlation of anti-RBD and NA is very high. The effectiveness (VE) of BNT162b2 in preventing SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatzakis, Angelos, Karabinis, Andreas, Roussos, Sotirios, Pantazis, Nikos, Degiannis, Dimitrios, Chaidaroglou, Antigoni, Petsios, Konstantinos, Pavlopoulou, Ioanna, Tsiodras, Sotirios, Paraskevis, Dimitrios, Sypsa, Vana, Psichogiou, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876471/
https://www.ncbi.nlm.nih.gov/pubmed/35214743
http://dx.doi.org/10.3390/vaccines10020285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876471/
https://www.ncbi.nlm.nih.gov/pubmed/35214743
http://dx.doi.org/10.3390/vaccines10020285

Ejemplares similares